Prosecution Insights
Last updated: August 17, 2026
Application No. 18/708,100

MOLECULAR METAL-BASED SINGLE CRYSTALLINE THIN FILM, COMPONENT HAVING SAME, AND METHOD FOR MANUFACTURING SINGLE CRYSTALLINE THIN FILM

Non-Final OA §103§112
Filed
May 07, 2024
Priority
Nov 10, 2021 — JP 2021-182911 +3 more
Examiner
NGUYEN, HAIDUNG D
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
National Institute for Materials Science
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
9m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
406 granted / 625 resolved
At TC average
Strong +28% interview lift
Without
With
+28.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
49 currently pending
Career history
671
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
48.9%
+8.9% vs TC avg
§102
26.1%
-13.9% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 625 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group II (claims 2-15) in the reply filed on 6/2/2026 is acknowledged. Claim 1, 16-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Groups I and IV, there being no allowable generic or linking claim. Priority Receipt is acknowledged of certified copies of papers submitted under 35 U.S.C. 119(a)-(d), which papers have been placed of record in the file. Information Disclosure Statement The information disclosure statements (IDS) submitted on 5/7/2024 and 6/15/2025 have been considered by the examiner. Initialed copies accompany this action. Drawings The Drawings filed 5/7/2024 are approved by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 6 and 11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 6 and 11 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Compound (I) of claim 6 and compound (III) of claim 11 fail to further limit the compound (chem. 5) recited in claim 2, which claims 6 and 11 are depended from. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 2-15 are rejected under 35 U.S.C. 103 as being unpatentable over Kobayashi et al (JP2020015680) in view of Kobayashi et al (Chem. Sci., 2020, 11, 11699). The machine translation of JP2020015680 is relied upon for the rejection purposes. Both references are cited in the filed IDS by applicant. Regarding claims 2, 6, 11, and 12, JP680 discloses a thin film containing compound A (para 0058-59), which is a tetrathiafulvalene derivative. Chem Sci. discloses a tetrathiafulvalene derivative, tetrathiafulvalene-extended dicarboxylate (TED) below that meets the claimed Chem 5, which is a single crystal (abstract). It would have been obvious to one of ordinary skill in the art before the filling date of the invention to use the tetrathiafulvalene-extended dicarboxylate (TED) disclosed by Chemi Sci. in place of the tetrathiafulvalene derivative of JP680, with a reasonable expectation of success for producing the thin film with high electrical conductivity. PNG media_image1.png 159 554 media_image1.png Greyscale Regarding claims 3, 5, 7, 8, and 13, given that the thin film of JP680 in view of Chem Sci. comprises of all the claimed elements in the claimed thin film, a person having an ordinary skill in the art would reasonably expect the thin film of JP680 in view of Chem Sci. to have the claimed conductivity and light transmittance. Regarding claims 4 and 9, JP680 discloses the film thickness is from 1nm to 1000nm (para 0011). Regarding claim 10, JP680 discloses the thin film comprising a mono to deca-molecular layer (para 0010). Regarding claims 14 and 15, JP680 discloses a transparent electrode comprises the thin film of claim 2 (para 0039-0040). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HAIDUNG D NGUYEN whose telephone number is (571)270-5455. The examiner can normally be reached M-Th: 10a-3p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HAIDUNG D NGUYEN/Primary Examiner, Art Unit 1761 6/24/2026
Read full office action

Prosecution Timeline

May 07, 2024
Application Filed
Jun 29, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12692333
DISPERSANT FOR POWER STORAGE DEVICE POSITIVE ELECTRODE
2y 8m to grant Granted Jul 28, 2026
Patent 12668517
FUNCTIONALIZED PHOSPHONATES, AND WATER-SOLUBLE SALTS AND N-OXIDE DERIVATIVES THEREOF, AND METHOD OF USE THEREOF AS SCALE INHIBITOR
2y 4m to grant Granted Jun 30, 2026
Patent 12671082
Electroactive Materials for Metal-Ion Batteries
1y 6m to grant Granted Jun 30, 2026
Patent 12658344
COPPER-ANF COMPOSITE CONDUCTOR FABRICATION
3y 5m to grant Granted Jun 16, 2026
Patent 12653205
OXYGEN ABSORBER TABLET
2y 6m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
93%
With Interview (+28.2%)
3y 0m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 625 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month